Generlac Solution
NDC Package 62135-892-47
Package Information
Generlac (lactulose) solution is a medication used by mouth or rectally to treat or prevent complications of liver disease (hepatic encephalopathy). This formulation utilizes a solution delivery system. Marketed by Chartwell Rx, Llc, this product is identified by NDC 62135-892 and is authorized under FDA application ANDA074603.
Identification & Billing
- RxCUI: 391937 - lactulose 10 GM in 15 mL Oral Solution
- RxCUI: 391937 - lactulose 667 MG/ML Oral Solution
- RxCUI: 391937 - lactulose 10 GM per 15 ML Oral Solution
- RxCUI: 391937 - lactulose 20 GM per 30 ML Oral Solution
- RxCUI: 544455 - GENERLAC 10 GM in 15 mL Oral Solution
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Rectal - Administration to the rectum.
Regulatory & Marketing
Hierarchy Structure
- 62135 - Chartwell Rx, Llc
- 62135-892 - Generlac
- 62135-892-47 - 473 mL in 1 BOTTLE
- 62135-892 - Generlac
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (62135-892). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62135-892-47 identifies a specific commercial package of 473 ml in 1 bottle of Generlac, a human prescription drug labeled by Chartwell Rx, Llc. This solution is formulated for oral; rectal use and contains lactulose as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chartwell Rx, Llc on October 31, 1996. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used by mouth or rectally to treat or prevent complications of liver disease (hepatic encephalopathy). It does not cure the problem, but may help to improve mental status. Lactulose is a colonic acidifier that works by decreasing the amount of ammonia in the blood. It is a man-made sugar solution.
How is this Chartwell Rx, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62135089247. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.